EyePoint Pharmaceuticals, Inc. (EYPT) released Loss for its fourth quarter that increased from the same period last year and missed the Street estimates.
The company's earnings totaled -$41.40 million, or -$0.64 per share. This compares with -$14.10 million, or -$0.33 per share, last year.
Analysts on average had expected the company to earn -$0.48 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period fell 17.4% to $11.59 million from $14.03 million last year.
EyePoint Pharmaceuticals, Inc. earnings at a glance (GAAP) :
-Earnings: -$41.40 Mln. vs. -$14.10 Mln. last year.
-EPS: -$0.64 vs. -$0.33 last year.
-Revenue: $11.59 Mln vs. $14.03 Mln last year.
For comments and feedback: editorial@rttnews.com